Brooks Laboratories Ltd Q1 FY23 consolidated net loss at Rs. 6.90 crores

Brooks Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 17.1577 crores during the period ended June 30, 2022 as compared to Rs. 28.6449 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. -6.9006 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -3.6029 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. -3.80 for the period ended June 30, 2022 as compared to Rs. -1.46 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 17.1577 crs	₹28.6449 crs	-40.10%
Net Profit	₹-6.9006 crs	₹-3.6029 crs	91.53%
EPS	₹-3.80	₹-1.46	160.27%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 17.1577 crores during the period ended June 30, 2022 as compared to Rs.22.3973 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.-6.9006 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-1.1426 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.-3.80 for the period ended June 30, 2022 as compared to Rs.-0.47 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 17.1577 crs	₹22.3973 crs	-23.39%
Net Profit	₹-6.9006 crs	₹-1.1426 crs	503.94%
EPS	₹-3.80	₹-0.47	708.51%

Shares of Brooks Laboratories Limited was last trading in BSE at Rs. 82.00 as compared to the previous close of Rs. 84.95. The total number of shares traded during the day was 6345 in over 78 trades.

The stock hit an intraday high of Rs. 86.95 and intraday low of 81.50. The net turnover during the day was Rs. 523380.00.

Source : Equity Bulls

Keywords

BrooksLaboratories Q1FY23 ResultUpdate